Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs

NCT01800487 is registered in ClinicalTrials.gov with Ramathibodi Hospital as lead sponsor.

NCT NCT01800487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs
Lead sponsor
Ramathibodi Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
July 31, 2013
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis